- Describe how substances can produce euphoric activity and how this may be modulated to try and reduce substance misuse.
- Summarize brain structures whose increase in activity correlates with the “euphoric effect” of substance use.
- Decipher areas of the CNS that may play a role in substance use disorder.
- Describe how the different types of cannabinoids may act on the reward system vs their potential for medicinal use.
Todd W. Vanderah, PhD, is professor and chair of Pharmacology and joint professor in the Departments of Neurology and Anesthesiology at The UArizona, College of Medicine – Tucson. He directs the MD/PhD Program and is the director of the Comprehensive Pain and Addiction Center in the Health Sciences. His research interests include mechanisms of cancer pain, neuronal integration in pain pathways, neurochemical release during conditions of neuropathy, neuronal plasticity, addiction, cannabinoid and opioid receptor pharmacology, as well as the discovery of novel targets for new medications. He is an author on several patents and has made great efforts in reaching out to the community to help educate on areas of substance use disorder and chronic pain. He is the principle investigator on multiple research grants, has authored over 180 original research articles, three human neuroscience books and two pharmacology text books.
The University of Arizona College of Medicine - Tucson is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Arizona College of Medicine - Tucson designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)ä. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All Faculty, CME Planning Committee Members, and the CME Office Reviewers have disclosed that they have no financial relationships with commercial interests that would constitute a conflict of interest concerning this CME activity.